UQ research heralds vaccine technology breakthrough
Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland's Faculty of Biological and Chemical Sciences. Research centre director Professor Robert Tindle said RSV cost millio...Emerging Research Heralds New Era of Breast Cancer Management
Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review//. The review reveals that new approaches in breast cancer imaging, investigations into the timing of chemotherapy, and research on breast cancer vaccines may lead to exciting new nonsurgical tools for the physician treating breast cancer patients. These new tools...Harnessing Immune System Power Heralds Next Era of Cancer Treatment
Canadian researchers have found that cells of the immune system can circulate throughout the body and attack cancerous tissues, if they are properly trained. Led by McMaster University's Jonathan Bramson, the researchers are now working to accelerate the ongoing immune system research through a new Cancer Immunotherapy Program, being launched with 3.5 million dollars in funding fr...Wet Weather Heralds the Mosquito Menace
Wet weather in some parts of the US and Canada heralds the menace of mosquitoes. The month long heavy rains have sent floodwaters rushing through large areas in both the countries . It has also left puddles of standing water all over the place, leading health officials to warn against the dangers of disease-carrying mosquitoes. "When we have more rain like this, our mosquito populatio...FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
Is FDA Equipped to Meet Pace of Innovations and a Health ConsciousPublic? WASHINGTON, April 30, 2007 /PRNewswire-USNewswire/ -- The Foodand Drug Administration (FDA) must adapt to the most significantchanges in the history of healthcare, Commissioner Andrew vonEschenbach told attendees at the Food and Drug Law Institute's 50thAnnual Conference April 12 in Bethesda, Md. FDA must fin...